Novanta Inc. (NOVT) fair value analysis

Nasdaq · Updated 2026-09-07

Novanta Inc. is a technology company that designs, manufactures, and markets precision photonics and software solutions for medical and industrial applications. The company operates globally with operations and customers across North America, Europe, and Asia.

Forward Fair Value verdict

Undervalued

Based on TickrTrends' weekly Forward Fair Value model, NOVT is trading at more than a 25% discount to estimated fair value.

NOVT currently ranks #73 of 199 Technology stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.

Last price: $148.34
Sector: Technology
12-month range: $100.82–$163.70

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: Low
RSI zone: Neutral
50/200-day trend: Mixed
52-week position: The top quarter of its range

What our data shows for NOVT

Our model validated 17 trailing price-to-earnings windows for NOVT, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $100.82–$163.70.
The 14-day relative strength index sits at a neutral 49.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for NOVT
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent NOVT news

TickrTrends' derived news-sentiment signal for NOVT is currently leaning positive, computed from recent coverage.

Novanta’s (NOVT) Second Quarter Shows Profits Outrunning Sales (finance.yahoo.com, 2026-09-04)
TickrTrends take: Novanta's second quarter results demonstrating profit growth that exceeded sales growth suggest operational efficiency improvements, which typically support a case for valuation expansion in the technology sector. TickrTrends' undervalued assessment indicates the market may not yet be fully pricing in the earnings power demonstrated by this operational performance. Investors focused on valuation metrics should monitor whether this profit-to-sales dynamic persists in coming quarters, as sustained margin strength could shift how the market values the company relative to its peers.
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026 (financialpost.com, 2026-08-28)
TickrTrends take: Novanta's presentation at the Baird Global Healthcare Conference provides an opportunity for investors to hear directly from management about the company's strategic direction and operational performance in the technology sector. Given TickrTrends' current assessment that NOVT is undervalued, this conference appearance could serve as a catalyst for the market to reassess the company's growth prospects and competitive positioning. Valuation-focused readers should monitor whether management commentary during the presentation addresses profitability drivers, market expansion opportunities, or operational efficiency improvements that might justify a revaluation upward from current levels.
Is It Too Late to Buy Novanta Inc (NOVT) After 3.1% Rally? GF Value Says Undervalued (gurufocus.com, 2026-08-26)
TickrTrends take: Novanta Inc operates in the Technology sector where valuation metrics significantly influence investment positioning. TickrTrends currently derives an undervalued verdict for NOVT, which aligns with the GF Value assessment referenced in the headline regarding price movement relative to intrinsic value. For valuation-focused readers, monitoring whether NOVT maintains its undervalued classification through upcoming earnings reports and changes in fundamental metrics will be important, as sector multiples and company-specific growth prospects can shift valuation conclusions.

What people are saying

Follow the NOVT conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is NOVT stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), NOVT is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.

What is NOVT's TickrTrends verdict?

NOVT's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.

How does NOVT compare to other Technology stocks?

NOVT ranks #73 of 199 Technology stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is NOVT overbought or oversold?

NOVT's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Technology fair-value coverage →

Head-to-head comparisons

NOVT vs AMD · NOVT vs CDW · NOVT vs CGNX · NOVT vs HLIT · NOVT vs LDOS